Skip to main content

Bedrocan To The Rescue! British Cannabis Patients Get 6 Months Relief

Post-Brexit scrambles by British patients on imported medical cannabis from Holland gets six-month reprieve with Dutch authorities and UK Home Office both agreeing on a short-term solution

British cannabis patients, who have fought for their children and relatives for years now, were given a sudden victory over cannabis prescriptions in October 2020. Only to have it taken away in December. Now a new government initiative is putting temporary measures in place for the next six months.

It seems like it all should have been taken care of, but like many things related to Brexit, cannabis was just one more thing that fell off the table.

Luckily, the highly vocal activists, according to the Edinburgh News, have managed to step into the breach and an import company in Glasgow has been able to restart cross channel supply. The Dutch government has concurred that as a temporary measure, it can export again, for six months, in a special deal with the British Home Office.

Of course, since the NHS is not yet authorizing the use of cannabinoid oil as the British Paediatric Association has not yet approved the same, families are at the harsh end of costs – around $1,200 a month.

This is not a new story, of course. What is unique, however, is how “fast” relatively speaking, authorities have moved, and in several countries – while failing of course to remedy the financial impact.

It sounds so Germany, with the exception of course that in Europe, this frenzied dance around cannabis started almost four years ago – and so far nobody has a lifetime prescription (as a few patients were beginning to get in the UK as of last fall). 

Regulatory Hell In Several Directions

There is no guarantee of course that the myriad levels of red tape will be cleared even in the next six months – for anything, let alone cannabis specifically. 

In the meantime, this is surely a boost for the domestic British cannabis industry, no matter how nascent it may be. It is also a wake-up call, globally, that the issue of cannabis regulations, in every country and region, needs a massive modern update if not reboot.

If the world is to change, dramatically, post-Covid, cannabis will undoubtedly be part of that mix. 

In the meantime, look for continued bumpy waters, in almost every jurisdiction and renewed activism from every quarter, including the industry for the next 12 months. As the threat of the Pandemic recedes, in other words, there is a very real possibility that frustrated proponents will make real the inevitability of history, finally, that full reform has always been.

Be sure to attend the International Cannabis Business Conference when it returns to Berlin in summer 2021!

The Rise Of “Localized” Recreational Cannabis Markets In Europe

Amsterdam is again raising the idea of a tourist-free cannabis industry, and Luxembourg plans the same. Will this drive reform across Europe or will COVID-19 reset the conversation?

The Dutch may have reinvigorated the cannabis discussion during the dark days of the 1980s and 1990s, and given the world the “coffee shop,” but so far in the 21st century, the Netherlands has been the centre of multiple failed attempts to “better regulate” itself, let alone give pointers to anyone else. The question is, however, how much will the Dutch “experiment” influence others across Europe? 

The latest attempt has been a cultivation tender which has been marred by missteps and delay, unprofessionalism and just like the German medical tender before it, scrapped to be revamped to another day.

This was followed by another call by Amsterdam (which sat out the national cultivation bid discussion like other larger Dutch cities) to regulate tourists right out of town. As strange as it seems during a global Pandemic that has decimated the tourist industry globally, the city of Amsterdam at least from the position of its civic leaders, is saying, “don’t come back.”

How successful this will be is another story. But will this idea become a “norm” as Luxembourg also begins to plan its own recreational experiment with similar rules, now slated theoretically for next year?

Nimbyism vs Tourism

Europe, as it begins to slide into the early days of smaller regulated markets, is about to hit the same snags as many U.S. states, in particular. Recreational cannabis is still not a winning political issue at the polls, even as medical cannabinoids have begun to become more accepted – and even if this too is still early days.

For that reason, the entire conversation is going to hit snags that have not been dealt with before. It is different when a federal government issues such rules vs. a state and so far there is little indication in Europe at least, that these are on course to be avoided.

That said, there is another discussion in town that may well wreck the best-laid plans of governments everywhere to keep sidestepping the conversation. And that is that economic development of every kind, including from the canna trade, is going to enter a different dimension post-Covid. 

Even if the tourists are not encouraged, in cookie-cutter NIMBY protests across regions, it will be tough to keep them entirely out. See the Spanish canna clubs as perhaps the best example of the same. Not to mention the rip-roaring potential of the human rights access court case that has the potential to completely rewrite the rules if the Court of Human Rights in Strasburg rules the way it should.

Be sure to book your tickets to the International Cannabis Business Conference when it returns to Europe in the summer of 2021!

Aphria Announces First Cannabis Harvest For Germany

The second growing facility for medical cannabis is about to deliver – but is this all going to be enough?

Aphria, now merged with Tilray, is edging ever closer to actually delivering medical cannabis product grown domestically – but they are still not quite there yet. Delivery appears to be now promised for Q1 this year, but there are many hurdles still, between now and then.

That said, beyond the individual successes of any company that has made it through this torturous process, what does this mean for the future of domestically produced cannabis outside the “big three?”

Steady As She Blows…Until After Covid…

There has been an acceptance since the early days of the cultivation tender in Germany that the initial bite at the apple – the first cultivation tender – would never produce enough for the growing and anticipated demand. This has been exacerbated by the many unavoidable delays in production thanks to Covid.

However post-Covid, with a renewed focus on domestic production and further green economic development, this is likely to morph into a very interesting discussion, even in Germany and even more particularly after the next general elections. And even more particularly with more established and regulated industries in Holland and Luxembourg, if not the Swiss, who are unlikely to sit this one out for long.

Beyond this, there is likely to be a growth in domestic production on the continent to feed other markets – like the Brexited UK. Obtaining the correct permits and beginning cultivation in this climate is likely to be just as torturous as it was before, if not slightly more painful for the next 18 months, but there is no way the activist British patients on the ground are going to stand for excuses, any more than they were before.

Bottom line? Long term the cannabis industry promises to be a growth industry that is integrated into other re-economic developments but it is not going to be quick, easy or cheap.

The Future Of Home Grow and Smaller Licensing In Europe

While the Canadians have the model down for smaller growers, this is an idea that has yet to be broadly adopted in Europe. That said, Italy has certainly opened the way, and it is unlikely that such ideas will be entirely thrown out the window, particularly if there is licensing revenue to be had. 

This does not mean that such developments will be easy to achieve. However, there is clearly a new day dawning on a number of fronts, and cannabis reform will be in the room from now on.

Be sure to attend the first post-COVID International Cannabis Business Conference in Berlin this summer!

Medical Cannabis Associated With Prolonged Reductions In Opioid Use

When it comes to cannabis reform, one of the biggest opponents to legalization, even medical legalization, has historically been the pharmaceutical industry.

It is a fact that when medical cannabis legalization comes to a particular state or country, the use of prescription drugs reduces because people replace some or all of their prescriptions with medical cannabis.

One area of the pharmaceutical industry that is particularly hit hard post-medical cannabis reform is the opioid sector of the pharmaceutical industry. Below is more information about it via a news release from our friends at NORML:

Patients who initiate the use of medical cannabis experience sustained reductions in their use of opioids, according to data published in the journal Cureus.

A pair of investigators assessed survey data from over 500 patients registered with three state-licensed medical cannabis practices in the northeastern region of the United States. Those surveyed had been prescribed opioids for chronic pain treatment for at least three months.

Forty-five percent of those surveyed reported decreasing their opioid usage following the initiation of cannabis therapy and another 40 percent of respondents acknowledged ceasing their use of opioids altogether – findings that are consistent with dozens of other studies. The majority of respondents (65 percent) reported that they sustained these changes for over one year.

Authors reported: “To our knowledge, this is one of the largest surveys of chronic pain patients who used opioids continuously for a minimum of three months and combined it with medical cannabis. Our results show a remarkable percentage of patients both reporting complete cessation of opioids and decreasing opioid usage by the addition of medical cannabis, with results lasting for over a year for the majority. … We believe our results lend further support that medical cannabis provided in a standardized protocol can lead to decreased pain and opioid usage, improved function, and quality of life measures, and even complete cessation of opioids in patients with chronic pain treated by opioids.”

Full text of the study, “A survey on the effect that medical cannabis has on prescription opioid medication usage for the treatment of chronic pain at three medical cannabis practice sites,” appears in Cureus. Additional information is available from the NORML fact sheet, “Relationship Between Marijuana and Opioids.”

The Dutch Cannabis Tender Hits The Skids

Like the German medical cannabis tender bid before it, the Dutch government has run into a few problems rolling out a regulated industry across the country – and the first tender for cultivation has imploded

One thing is for sure. Governments find it very hard to roll out a federally controlled tender bid for the cultivation of cannabis. Everywhere.

Here is the thing the U.S., however, can take away from the following story. Don’t smirk – there is nothing about a state-driven licensed process on that side of the pond that is anywhere as complex if not complicated as doing it on this side of the Atlantic. And that is before the inevitable flubs and stupid politics get mixed in.

Here is the quick update. The first federally overseen Dutch attempt to finally regulate the cultivation of cannabis bound for domestic coffee shops (outside of major cities, which already decided to sit this out in favour of their own systems), has just hit formal skids.

Here is the upshot. The Dutch bid selections (9 rather than the initial expected 10 after one of these got disqualified) will all have to be reconsidered. Multiple errors in selecting winners, including leaving out the wishes of local councils, multiple entries by the same firm (this was a “lottery” after all) and other very unprofessional issues have all arisen in the last week as the bid was supposed to be decided. 

Even Dutch growers, and those who back them will concur that this was not only a highly foreseeable if not preventable situation. Not to mention the logic at work in reconfiguring the process is absolutely inescapable. Business plans as well as the disclosure of investor names are mandatory (for starters).

Unsurprisingly, the referees to all of this are circling wagons – but there is going to clearly be another bid redo in an environment where free wheeling cannapreneurial efforts are hitting the skids after being exposed to even the most minimal and logical regulatory muster.

In the meantime, enterprising firms interested in having their shot at a “little cannabis farm” in Holland should be aware that the decision process is far from over.

For an inside look at some of the most pressing regulatory, cultivation and tender bid issues in Europe, be sure to book your tickets to the International Cannabis Business Conference when it returns to Europe.

Brexit Interrupts Dutch Supply Of Medical Cannabis To British Patients

The new cross Channel “order” splitting the UK from the continent hits cannabis patients first and hard

As was easy to predict, Brexit interrupted vital supplies of medical cannabis (from Holland’s Bedrocan) from reaching British patients. The news hit families on December 15 – less than two weeks before the implementation of new rules and regs. Indeed, the families involved, well used to the need for a highly visible public campaign, made such a stink that the political repercussions are already forcing the government to look for alternatives. 

They are not that hard to find – if you know the industry.

But the question remains, since this was so predictable, why wasn’t this thought about before?

In the short term, at least according to the Independent in the UK who picked up the story after The Guardian broke it, government officials are trying to find solutions and they should not be that hard to find.

Dutch law, however, as some media are reporting, most certainly does not “prohibit” the export of medical cannabis – see Germany right next door.  If that were true, indeed most EU GMP compliant German medical cannabis flos could not have been dispensed via pharmacies so far. 

The process had previously been certified via “issuing British prescriptions” in Holland and having them filled this way.

All the British government actually has to do, in fact, is follow the lead already set by Germany and indeed by Israel in the past. Buy in bulk, flos if necessary, and extract it in the UK. There are already facilities that are being set up to do the same. 

But that kind of thinking, if not process creation is so far sadly absent in just about all things Brexit. Just look at the mess of Channel crossings. Cannabis was always going to be an early victim of the melee.

The question now, among those who work in complex supply chain issues like this all the time – and for many reasons – is how to mend the gap, not only in the short term, but permanently.

Make sure you book your tickets to the International Cannabis Business Conference when it returns to Europe in the summer of 2021!

How Much Legal Cannabis Did Illinois Sell In 2020?

Currently, 15 states in the U.S. have legalized cannabis for adult-use along with Washington D.C. Some of those states already have legal adult-use cannabis sales underway, while others, mostly the 2020 class of states, have yet to launch legal sales.

The first state in the history of the United States to legalize adult-use cannabis sales by legislative action was Illinois. Every other state that legalized cannabis before Illinois, with the exception of Vermont, legalized cannabis via the ballot box.

In the case of Vermont, lawmakers passed a legalization measure, however, the measure did not legalize regulated adult-use cannabis sales – just possession and cultivation.

Illinois just wrapped up its first year of adult-use cannabis sales, and the year-end totals are staggering. Per Chicago Tribune:

The year 2020 dawned with thousands of people lined up, some overnight, waiting to be among the first to buy legal recreational marijuana in Illinois.

As the long, strange year comes to an end, people are lined up at food banks, to get coronavirus nasal swabs and in some cases, to be among the first to receive a vaccine that may mark the beginning of the end of the COVID-19 pandemic.

And people are still buying weed. Lots of it.

Despite the massive economic disruption wrought by the pandemic, 80 recreational cannabis dispensaries have opened in Illinois and business is on pace to top $1 billion in 2020, including medical marijuana sales.

Illinois’ legal cannabis industry is still very young by many standards, and to top a billion dollars in sales in the first year is significant. To put the sales figure into perspective, Colorado’s first year of legal sales post-legalization (2014) was roughly $684 million.

To be fair, Illinois has a significantly larger population than Colorado, however, Colorado’s medical industry was much older so a better industry framework was already in place, and Colorado had the national monopoly on legal adult-use sales and sold a lot of cannabis to tourists.

Illinois’ cannabis laws are not perfect, and the industry has a lot of room to improve, but what happened in Illinois in 2020 was pretty remarkable, and will hopefully encourage legislators in other prohibition states to pass legalization measures sooner rather than later.

Ireland’s Transport Minister: No Cannabis Legalization In 2021

In many ways 2020 was one of the worst years of all time, yet, from a purely cannabis reform and industry standpoint, 2020 was a solid year by many measures.

Last year had one very big disappointment in the form of an unsuccessful vote in New Zealand, where voters shot down a nationwide cannabis legalization measure.

However, putting New Zealand’s vote aside, 2020 was stellar for cannabis efforts in many parts of the world, with the legal cannabis industry putting up record figures.

Several states legalized cannabis for adult use in the United States, and several countries increased momentum for reform at the international level going into 2021.

One country that will not be legalizing cannabis for adult use in 2021 is Ireland according to Green Party leader Eamon Ryan. Per The Irish Sun:

IRELAND is not ready to legalise cannabis next year, Green Party leader Eamon Ryan has claimed.

It comes as People Before Profit plan to put forward a motion in the Dail next year to legalise the drug in Ireland.

Earlier this month, PBP TD Gino Kenny said his party will bring forward legislation to try end the prohibition of cannabis in Ireland.

As of right now, only Uruguay and Canada have legalized cannabis for adult use. Italy’s Supreme Court ruled cannabis prohibition to be unconstitutional, but lawmakers in Italy have not passed a legalization measure to fully implement the Court’s decision.

Only time will tell which country on the European continent becomes the first to legalize, however, it will likely not be Ireland if current trends persist.

Dutch Cannabis Licensing Scheme Hits Local Protests

Plans to replace the production of blackberries with coffee-shop bound cannabis hit skids over NIMBYism at proposed grow sites for new Dutch licenses.

If it sounds like a scene straight out of a comedy, not to mention Colorado circa 2015 or so, just at a far lower altitude and probably still far more windmills, it is. The only problem is that it is also a tragedy. About lingering stigma, confusion, and more about the plant, if not its effects.

In these times of Covid, it also shows how this continued confusion has lasting effects – starting with jobs.

As the Dutch government proceeds with a pilot project to create ten licensed growers to supply the country’s coffee shops outside of big cities, it has run into its first major snag.

The residents of Etten-Leur, on the Belgian border, have trigged large local protests over a pending plan to replace blackberry crops with cannabis. There is now a request by the local mayor to the central government opposing the scheme. And the selection of the finalists for the 10 Dutch licenses has not even been decided yet.

The legal status of cannabis has everything to do with this. So far, Holland has not formally changed its national laws to legitimise the recreational cannabis industry. Indeed even this first trial as an attempt to do so has been opposed by its own large cities who maintain local controls on a still-flourishing industry.

The largest problem however now facing this model is larger scale, regulated cultivation. With Dutch residents now protesting the placement of larger corporate grows, the entire project may run into problems before it is ever rolled out.

Where To Grow New Canna Crops?

Holland produces a great deal of the medical cannabis flos that flows across the border to Germany – which has had its own ongoing problems with cannabis cultivation bids. Indeed, the first tender for medical cannabis, launched in the spring of 2017, has faced delay after delay in delivering domestically cultivated crops to German patients.

In Holland, the issue is already contentious – starting with the fact that the government could not even get cities to go along with a so-called “national plan.”

If smaller cities and municipalities also get into the act, the first licensing scheme for Holland, regulated on a federal level, will quickly fail.

For this reason, no matter how bad the news, it is also a step forward on the issue overall – in both Holland and the rest of Europe (see Luxembourg for starters).

Having a cannabis presence is one thing. Having a regulated cannabis industry is another.

And as American, if not Canadian communities learned long ago, the transition is always bumpy. For one reason or another. The good news, no matter the uncomfortable delays so far, is that it is happening at all

Be sure to book your tickets when the International Cannabis Business Conference returns to Europe this summer.